Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dan Troy | M | 64 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Chester Koczynski | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Ezra Suleiman | M | 82 |
Princeton University
| 45 years |
| Adrian Rawcliffe | M | 52 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| David Redfern | M | 57 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Curran Simpson | M | 62 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 9 years |
| Deirdre Connelly | F | 63 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 years |
| H. Watkins | M | 71 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 years |
| David Mott | M | 58 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 16 years |
| Gregory Norden | M | 66 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 1 years |
| David Southwell | M | 63 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 4 years |
| Stephen C. Ferruolo | M | - |
Princeton University
| 3 years |
| Andrea Baumann Lustig | F | - |
Princeton University
| 5 years |
| Darren Cline | M | 59 | 9 years | |
| William W. Freimuth | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 years |
| Eric Dobmeier | M | 55 | 16 years | |
| John McLaughlin | M | 72 | 9 years | |
| George Morrow | M | 72 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 1 years |
| Colin Goddard | M | 64 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 2 years |
| Reginald Seeto | M | 52 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 3 years |
| Alpna Seth | M | 60 | 5 years | |
| Roger Dansey | M | 67 | 5 years | |
| James H. Davis | M | 72 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 15 years |
| Augustine Lawlor | M | 67 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 years |
| Robert C. Young | M | 84 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 years |
| Lynn A. Stout | F | 66 |
Princeton University
| 6 years |
| Maxine Gowen | M | 66 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 4 years |
| Barry A. Labinger | M | 60 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 years |
| A. Karmel | M | 73 |
Princeton University
| 3 years |
| Roberto Barragan | M | 54 |
Princeton University
| 4 years |
| Thomas S. Ward | M | - |
Princeton University
| 4 years |
| Douglas Lederman | M | - |
Princeton University
| 4 years |
| Paul Chamberlain | M | 60 |
Princeton University
| 4 years |
| Jamie Forese | M | 61 |
Princeton University
| 4 years |
| Juan Sabater | M | 59 |
Princeton University
| 4 years |
| Scott Anderberg Callon | M | 59 |
Princeton University
| 4 years |
| John Evans | M | 66 |
Princeton University
| 4 years |
| Gordon F. Kingsley | M | - |
Princeton University
| 4 years |
| Brendan O'Halloran | M | 61 |
Princeton University
| 4 years |
| William Jennings | M | 80 |
Princeton University
| 4 years |
| Charlie Pollnow | M | - |
Princeton University
| 4 years |
| Jonathan Gallen | M | 64 |
Princeton University
| 4 years |
| David Petraeus | M | - |
Princeton University
| 4 years |
| Lloyd Chao | M | - |
Princeton University
| 4 years |
| John Clark | M | - |
Princeton University
| 4 years |
| Nan Hayworth | M | - |
Princeton University
| 4 years |
| Michelle Williams | M | 62 |
Princeton University
| 4 years |
| Thaddeus Huetteman | M | - |
Princeton University
| 2 years |
| Elizabeth Haley Rockwell | F | - |
Princeton University
| 4 years |
| Robin Taylor | M | - | 1 years | |
| Tom Blum | M | - |
Princeton University
| 4 years |
| Glenn N. Huber | M | - |
Princeton University
| 4 years |
| H. Seidel | M | 59 |
Princeton University
| 4 years |
| Margaret Laws | F | - |
Princeton University
| 4 years |
| Bruce Reed | M | 64 |
Princeton University
| 4 years |
| William J. Cooper | M | - |
Princeton University
| 4 years |
| Kathleen Larrimer Beckmann | F | - |
Princeton University
| 4 years |
| Haley Rockwell Elmlinger | F | - |
Princeton University
| 4 years |
| Florence D. Hudson | F | 64 |
Princeton University
| 4 years |
| Jim Cohen | M | - |
Princeton University
| 4 years |
| Cornel Ronald West | M | 71 |
Princeton University
| 3 years |
| Ranch C. Kimball | M | - |
Princeton University
| 4 years |
| Stephen Donald Dowd | M | 60 |
Princeton University
| 4 years |
| Debra Yu | M | 59 |
Princeton University
| 4 years |
| David Pierson Tuttle | M | 64 |
Princeton University
| 4 years |
| Tim Evnin | M | - |
Princeton University
| 4 years |
| Alexandra Lebenthal | F | 60 |
Princeton University
| 4 years |
| Michael Thaman | M | 60 |
Princeton University
| 4 years |
| Scott Allen Billeadeau | M | 63 |
Princeton University
| 4 years |
| Steven L. Teig | M | - |
Princeton University
| 4 years |
| Kevin M. Weiss | M | 66 |
Princeton University
| 4 years |
| Gregory Scott Werlinich | M | - |
Princeton University
| 4 years |
| Andrew Evans Sinwell | M | - |
Princeton University
| 4 years |
| John Ingram | M | 62 |
Princeton University
| 5 years |
| Andrea Jung | F | 64 |
Princeton University
| 4 years |
| David Franklin Sand | M | - |
Princeton University
| 4 years |
| Timothy Baer | M | 63 |
Princeton University
| 4 years |
| Charles S. Trump | M | 62 |
Princeton University
| 4 years |
| Hugh Jeffrey Leonard | M | 69 |
Princeton University
| 3 years |
| Richard Raymond Ong | M | 67 |
Princeton University
| 4 years |
| Mark Weintraub | M | - |
Princeton University
| 4 years |
| Seth Lederman | M | 66 |
Princeton University
| 4 years |
| Rich McKay | M | 65 |
Princeton University
| 4 years |
| Steven R. Schoenfeld | M | - |
Princeton University
| 4 years |
| David B. Ray | M | - |
Princeton University
| 4 years |
| Caroline Petro Gately | F | - |
Princeton University
| 4 years |
| John M. Goldsmith | M | 61 |
Princeton University
| 4 years |
| Richard Tavoso | M | - |
Princeton University
| 4 years |
| Gordon Ritter | M | 59 |
Princeton University
| 4 years |
| Brad Greenwald | M | - |
Princeton University
| 4 years |
| J. Blair Richardson | M | - |
Princeton University
| 4 years |
| Michael Menkowitz | M | - |
Princeton University
| 4 years |
| Leland Putterman | M | 64 |
Princeton University
| 4 years |
| Yadin Kaufmann | M | - |
Princeton University
| 4 years |
| Merrick Andlinger | M | - |
Princeton University
| 4 years |
| Don McDonald | M | 62 |
Princeton University
| 4 years |
| Arnim Sanchez Holzer | M | 65 |
Princeton University
| 4 years |
| Ira Starr | M | - |
Princeton University
| 4 years |
| John E. Parks | M | - |
Princeton University
| 4 years |
| Stephen Ruvituso | M | - |
Princeton University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Lechleider
- Personal Network
